Form 990 for tax year 2023
Filed by T A G TREATMENT ACTION GROUP INC.
Totals
- Total revenue
- $4,736,176
- Total expenses
- $3,743,080
- Contributions and grants received
- $4,682,755
- Grants paid
- $296,958
- Program service revenue
- $43,188
- Investment income
- $9,829
- Other revenue
- $404
- Total assets, end of year
- $4,624,032
- Total liabilities, end of year
- $1,012,949
- Net assets or fund balances, end of year
- $3,611,083
- Program services expenses (Part IX)
- $2,964,703
- Management and general expenses
- $477,045
- Fundraising expenses
- $301,332
- Program service expenses (Part III)
- $2,964,703
Program services were 79.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$204,526
-
1e · Government grants (contributions)
$109,441
-
1f · All other contributions, gifts and grants
$4,368,788
-
1g · Noncash contributions included above
$5,874
-
2a · Program service revenue: OTHER PROGRAM INCOME
total $43,188 · related or exempt $43,188
-
3 · Investment income
total $9,829 · excluded $9,829
-
8a · Fundraising events: gross income
$37,625
-
8a · Fundraising events: contributions included on line 1c
$204,526
-
8b · Fundraising events: direct expenses
$37,625
-
8c · Net income from fundraising events
total $0
-
10a · Gross sales of inventory
$17,604
-
10b · Cost of goods sold
$17,200
-
10c · Net income from sales of inventory
total $404 · excluded $404
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $16,593 · program services $16,593
-
3 · Grants to foreign organizations and individuals
total $280,365 · program services $280,365
-
5 · Compensation of officers, directors and key employees
total $328,861 · program services $199,382 · management and general $66,387 · fundraising $63,092
-
7 · Other salaries and wages
total $1,459,285 · program services $1,143,658 · management and general $242,866 · fundraising $72,761
-
9 · Other employee benefits
total $405,456 · program services $312,123 · management and general $67,742 · fundraising $25,591
-
10 · Payroll taxes
total $131,391 · program services $99,140 · management and general $22,581 · fundraising $9,670
-
11d · Fees: lobbying
total $13,905 · management and general $13,905
-
11g · Fees: other
total $365,171 · program services $338,127 · management and general $15,270 · fundraising $11,774
-
12 · Advertising and promotion
total $1,986 · program services $120 · fundraising $1,866
-
13 · Office expenses
total $62,590 · program services $46,304 · management and general $5,039 · fundraising $11,247
-
14 · Information technology
total $34,490 · program services $28,506 · management and general $3,219 · fundraising $2,765
-
16 · Occupancy
total $161,682 · program services $121,818 · management and general $26,714 · fundraising $13,150
-
17 · Travel
total $238,403 · program services $218,176 · management and general $3,404 · fundraising $16,823
-
19 · Conferences, conventions and meetings
total $45,089 · program services $44,999 · fundraising $90
-
22 · Depreciation, depletion and amortization
total $5,564 · program services $4,191 · management and general $920 · fundraising $453
-
23 · Insurance
total $24,882 · program services $18,747 · management and general $4,111 · fundraising $2,024
-
24a · Other expenses: FUNDRAISING EVENTS
total $59,609 · fundraising $59,609
-
24b · Other expenses: PRINTING & PUBLICATIONS
total $51,747 · program services $44,448 · management and general $28 · fundraising $7,271
-
24c · Other expenses: DUES AND SUBSCRIPTIONS
total $44,644 · program services $43,731 · management and general $205 · fundraising $708
-
24d · Other expenses: MISCELLANEOUS
total $10,066 · program services $4,275 · management and general $3,353 · fundraising $2,438
-
24e · All other expenses
total $1,301 · management and general $1,301
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $15,185 · end of year $48,553
-
2 · Savings and temporary cash investments
beginning of year $1,495,550 · end of year $1,394,085
-
3 · Pledges and grants receivable
beginning of year $555,526 · end of year $1,796,031
-
4 · Accounts receivable
beginning of year $3,756 · end of year $8,271
-
9 · Prepaid expenses and deferred charges
beginning of year $86,189 · end of year $72,871
-
10a · Land, buildings and equipment: cost or other basis
$98,526
-
10b · Land, buildings and equipment: accumulated depreciation
$84,961
-
10c · Land, buildings and equipment, net
beginning of year $15,931 · end of year $13,565
-
15 · Other assets
beginning of year $1,377,141 · end of year $1,290,656
-
17 · Accounts payable and accrued expenses
beginning of year $38,723 · end of year $74,007
-
25 · Other liabilities
beginning of year $892,568 · end of year $938,942
-
27 · Net assets without donor restrictions
beginning of year $1,965,644 · end of year $1,775,039
-
28 · Net assets with donor restrictions
beginning of year $652,343 · end of year $1,836,044
Mission and programs · 2023
Mission
TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS.
-
SEE SCHEDULE OTUBERCULOSIS (TB) PROGRAMACCORDING TO THE LATEST REPORT FROM THE WORLD HEALTH ORGANIZATION (WHO), "TB REMAINED THE WORLD'S SECOND LEADING CAUSE OF DEATH FROM A SINGLE INFECTIOUS AGENT IN 2022, AFTER COVID-19, AND GLOBAL TB TARGETS HAVE EITHER BEEN MISSED OR REMAIN OFF TRACK. THE REPORTED GLOBAL NUMBER OF PEOPLE NEWLY DIAGNOSED WITH TB WAS 7.5 MILLION IN 2022. THIS IS THE HIGHEST NUMBER SINCE WHO BEGAN GLOBAL TB MONITORING IN 1995, ABOVE THE PRE-COVID BASELINE (AND PREVIOUS HISTORICAL PEAK) OF 7.1 MILLION IN 2019, AND UP FROM 5.8 MILLION IN 2020 AND 6.4 MILLION IN 2021... GLOBALLY IN 2022, TB CAUSED AN ESTIMATED 1.30 MILLION DEATHS (95% UI: 1.18-1.43 MILLION). [THIS TOTAL INCLUDES 167 000 DEATHS FROM TB AMONG PEOPLE WITH HIV, WHICH ARE OFFICIALLY CLASSIFIED AS DEATHS FROM HIV/AIDS.] THIS WAS DOWN FROM BEST ESTIMATES OF 1.4 MILLION IN BOTH 2020 AND 2021 AND ALMOST BACK TO THE LEVEL OF 2019. COVID-RELATED DISRUPTIONS ARE ESTIMATED TO HAVE RESULTED IN ALMOST HALF A MILLION EXCESS DEATHS FROM TB IN THE THREE YEARS 2020-2022, COMPARED WITH THE NUMBER THAT WOULD HAVE OCCURRED IF PRE-PANDEMIC TRENDS HAD BEEN MAINTAINED. THE NET REDUCTION IN THE GLOBAL NUMBER OF DEATHS CAUSED BY TB FROM 2015 TO 2022 WAS 19%, FAR FROM THE WHO END TB STRATEGY MILESTONE OF A 75% REDUCTION BY 2025.... WORLDWIDE, AN ESTIMATED 10.6 MILLION PEOPLE (95% UI: 9.9-11.4 MILLION) DEVELOPED TB IN 2022, UP FROM BEST ESTIMATES OF 10.3 MILLION IN 2021 AND 10.0 MILLION IN 2020.... THE GLOBAL GAP BETWEEN THE ESTIMATED NUMBER OF PEOPLE DEVELOPING TB (INCIDENT CASES) AND THE REPORTED NUMBER OF PEOPLE NEWLY DIAGNOSED WITH TB (NOTIFIED CASES) NARROWED TO A BEST ESTIMATE OF 3.1 MILLION IN 2022, DOWN FROM AROUND 4 MILLION IN BOTH 2020 AND 2021 AND BACK TO THE PRE-PANDEMIC LEVEL OF 2019. GLOBALLY, AN ESTIMATED 410 000 PEOPLE (95% UI: 370 000- 450 000) DEVELOPED MULTIDRUG-RESISTANT OR RIFAMPICIN- RESISTANT TB (MDR/RR-TB) IN 2022. THE NUMBER OF PEOPLE DIAGNOSED AND STARTED ON TREATMENT WAS MUCH LOWER: 175 650 PEOPLE IN 2022, EQUIVALENT TO ABOUT TWO IN FIVE OF THOSE IN NEED AND STILL BELOW THE PRE-PANDEMIC LEVEL OF 181 533 PEOPLE IN 2019. GLOBAL TARGETS SET AT THE FIRST UN HIGH-LEVEL MEETING ON TB FOR THE 5-YEAR PERIOD 2018-2022 WERE NOT ACHIEVED. TREATMENT SUCCESS RATES HAVE IMPROVED: TO 88% FOR PEOPLE TREATED FOR DRUG-SUSCEPTIBLE TB AND 63% FOR PEOPLE WITH MDR/RR-TB." THOUGH PREVENTABLE AND CURABLE, TUBERCULOSIS (TB) IS THE LEADING CAUSE OF DEATH OF PEOPLE WITH HIV AND ONCE AGAIN THE LEADING INFECTIOUS KILLER GLOBALLY NOW THAT THE ACUTE PHASE OF THE COVID-19 PANDEMIC HAS ABATED. RECOGNIZING THAT MUCH MORE PROGRESS COULD BE MADE IF EXISTING TOOLS WERE FULLY IMPLEMENTED, AND THAT MORE RESEARCH IS NEEDED TO END TB, TAG'S TB PROGRAM STRENGTHENS EVIDENCE-DRIVEN AND HUMAN RIGHTS-BASED ADVOCACY BOTH FOR BETTER TB RESEARCH, AND FOR HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE, THAT MEET THE NEEDS OF AFFECTED COMMUNITIES.TAG'S TB PROGRAM EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE UNDERSTANDING OF TB AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROGRAM WORKS WITH COMMUNITY ADVOCATES, COMMUNITY ADVISORY BOARDS, RESEARCHERS, POLICY MAKERS, DEVELOPERS, AND DONORS TO ENSURE NEEDS-DRIVEN RESEARCH TO IMPROVE OPTIONS FOR TB PREVENTION, DIAGNOSIS, AND TREATMENT. THE TB PROGRAM PUBLISHES AN ANNUAL REPORT ON TB RESEARCH FUNDING TRENDS, AND ADVOCATES FOR ALL GOVERNMENTS OF THE WORLD TO STEP UP AND CONTRIBUTE THEIR "FAIR SHARE" INVESTMENTS IN TB R&D.THE TB PROGRAM WORKS WITH RESEARCHERS, ACTIVISTS, AND POLICYMAKERS AROUND THE WORLD TO ENSURE TRANSPARENCY AND UNIVERSAL, EQUITABLE, AFFORDABLE ACCESS TO PROVEN INTERVENTIONS, FROM EARLY IN THE RESEARCH PROCESS THROUGH REGULATORY APPROVAL TO GLOBAL AND NATIONAL GUIDELINES DEVELOPMENT AND PRODUCT PRICING. TAG'S POLICY TEAM SUPPORTS THE TB PROGRAM IN EDUCATING U.S. LEGISLATORS AND OFFICIALS ON TB PRIORITIES, AND LEADS DOMESTIC WORK AT THE LOCAL, STATE, AND NATIONAL LEVEL TO SUPPORT AMBITIOUS AND EVIDENCE-BASED PROGRAMMING TO END.
Expenses $1,558,117 · Grants $282,608 · Revenue $43,188
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $723,383 · Grants $8,350
-
SEE SCHEDULE OHEPATITIS C VIRUS (HCV) PROGRAMACCORDING TO THE WORLD HEALTH ORGANIZATION'S GLOBAL HEPATITIS REPORT 2024, OF THE 50 MILLION PEOPLE ESTIMATED TO BE LIVING WITH CHRONIC HEPATITIS C VIRUS INFECTION, ONLY 36% WERE DIAGNOSED BETWEEN 2015 AND 2022, AND 20% RECEIVED TREATMENT. IN 2022 ALONE, ABOUT 1 MILLION NEW HCV INFECTIONS AND APPROXIMATELY 221 000 HCV-RELATED DEATHS WERE REGISTERED, MOSTLY FROM CIRRHOSIS AND HEPATOCELLULAR CARCINOMA. ABOUT 2.3 MILLION PEOPLE (6.2%) OF THE ESTIMATED 37.7 MILLION LIVING WITH HIV GLOBALLY IN 2020 HAD SEROLOGICAL EVIDENCE OF PAST OR PRESENT HCV INFECTION. TAG'S HCV PROGRAM HAS BEEN AT THE FOREFRONT OF A GLOBAL HCV EDUCATION AND ADVOCACY MOVEMENT, WORKING IN COLLABORATION WITH AFFECTED COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFE-SAVING INFORMATION, HIGH QUALITY AND AFFORDABLE TESTING AND CURES, AND SUPPORTIVE ENVIRONMENTS FOR UNDERSERVED POPULATIONS UNIVERSALLY AVAILABLE. THIS INCLUDES TRACKING THE PIPELINE FOR HCV INNOVATIONS, INCLUDING THE LATEST PANGENOTYPIC TREATMENTS, DIAGNOSTICS, AND LONG-ACTING INJECTABLES, AND INCREASING COMMUNITIES' DIAGNOSTICS AND TREATMENT LITERACY. GLOBALLY, TAG PROVIDES TECHNICAL ASSISTANCE TO BUILD LEADERSHIP CAPACITY FOR ADVANCING NATIONAL ELIMINATION CAMPAIGNS AND AMPLIFYING COMMUNITY VOICES-ESPECIALLY THOSE OF KEY POPULATIONS SUCH AS PEOPLE WHO USE DRUGS, SEX WORKERS, PRISONERS, MIGRANTS, AND MEN WHO HAVE SEX WITH MEN IN PLANNING AND POLICY DEVELOPMENT.TAG'S HCV PROGRAM WORKS TO OVERCOME BARRIERS TO HCV PREVENTION AND CARE, INCLUDING LIMITED DONOR FUNDING FOR HCV, RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, PATENT, AND PRICING BARRIERS, LIMITED VOLUNTARY LICENSING AND DELAYS IN DRUG REGISTRATION BY ORIGINATOR COMPANIES. THE HCV PROGRAM ADVOCATES FOR HARM REDUCTION AND DRUG DECRIMINALIZATION EFFORTS, INCLUDING SUPPORT FOR OVERDOSE PREVENTION AND SAFE CONSUMPTION SITES AS UNSAFE INJECTION DRUG USE IS A MAJOR ROUTE OF HCV TRANSMISSION.IN THE U.S., TAG'S POLICY TEAM WORKS AT THE LOCAL, STATE, AND NATIONAL LEVELS: ADVOCATING FOR VIRAL HEPATITIS FUNDING, CHAMPIONING TREATMENT COVERAGE FOR PEOPLE WHO USE DRUGS, PEOPLE WHO ARE UNSTABLY HOUSED AND INCARCERATED OR OTHERWISE MARGINALIZED PEOPLE, ENCOURAGING VOLUME-BASED PRICING DEALS FOR DAAS, STRENGTHENING NATIONAL SURVEILLANCE, AND SUPPORTING COMMUNITY ENGAGEMENT. TAG'S ADVOCACY HELPED ADVANCE COVERAGE FOR UNIVERSAL ADULT HCV SCREENING AND DRIVE NEW YORK STATE'S COMMITMENT TO ELIMINATE HCV -- THE FIRST IN THE NATION! -- WITH TAG PARTICIPATING IN THE RESULTANT STATEWIDE HCV ELIMINATION TASK FORCE.
Expenses $323,533 · Grants $6,000
-
SEE SCHEDULE OUS & GLOBAL HEALTH POLICY PROGRAMTAG US AND GLOBAL HEALTH POLICY PROGRAM STAFF WORK WITH PROGRAM TEAMS TO DEVELOP SPECIFIC POLICY GOALS AND STRATEGIES TO ADVANCE THE END OF THE HIV, TUBERCULOSIS (TB), AND HEPATITIS C (HCV) EPIDEMICS. THIS INCLUDES SECURING FUNDING FOR, AND SHAPING POLICY RELATED TO, GOVERNMENT AND MULTILATERAL PROGRAMS THAT PROVIDE DIRECT SERVICES, ISSUE GUIDELINES, COORDINATE ADMINISTRATION, AND CONDUCT RESEARCH ON EACH OF TAG'S PRIORITY HEALTH AREAS. WORKING WITH PARTNERS IN THE PUBLIC AND PRIVATE SECTORS, THE POLICY PROGRAM ADVANCES A HUMAN-RIGHTS BASED APPROACH TO EVIDENCE-INFORMED POLICY. THIS INVOLVES EDUCATING STAKEHOLDERS AND DECISION MAKERS; AUTHORING POLICY BRIEFS CONTAINING INFORMATION AND RECOMMENDATIONS; CONVENING PARTNERS; LEADING AND CONTRIBUTING TO COALITIONS; SUBMITTING TESTIMONY, PUBLIC COMMENTS, REPORT LANGUAGE, AND POLICY PROPOSALS; PROVIDING TECHNICAL ASSISTANCE AND CAPACITY BUILDING; AND FACILITATING ADVOCACY OPPORTUNITIES FOR COMMUNITIES MOST DIRECTLY AFFECTED BY THE POLICIES CONCERNED.
Expenses $359,670
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
Robert W LennonROBERT W LENNON
PRESIDENT
- Total calculated
- $0
- Hours/week
- 3.5
-
Ivy Kwan ArceIVY KWAN ARCE
TREASURER
- Total calculated
- $0
- Hours/week
- 4.5
-
Mrinal VikramMRINAL VIKRAM
SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
Jim AquinoJIM AQUINO
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Moe Ari Brownleft 1023MOE ARI BROWNLEFT 1023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
Nick DebsNICK DEBS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
Joy EpisallaJOY EPISALLA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 3.5
-
Kevin GoetzKEVIN GOETZ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 3
-
Jameel JiwaniJAMEEL JIWANI
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Richard Lynn PhDRICHARD LYNN PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 4
-
Robert MonteleoneROBERT MONTELEONE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2.5
-
Laura MorrisonLAURA MORRISON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2.5
-
David PuenteDAVID PUENTE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 3.5
-
Michael Monteroleft 1023MICHAEL MONTEROLEFT 1023
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0
-
Mark HarringtonMARK HARRINGTON
EXECUTIVE DIRECTOR
- Total calculated
- $192,456
- From this org
- $174,202
- From related orgs
- $0
- Other
- $18,254
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $174,202
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $18,254
- Filer's total
- $192,456
-
Jason KirkJASON KIRK
CHIEF OPERATING OFFICER
- Total calculated
- $132,904
- From this org
- $114,650
- From related orgs
- $0
- Other
- $18,254
- Hours/week
- 40
-
Lindsay McKennaLINDSAY MCKENNA
TB PROGRAM CO-DIRECTOR
- Total calculated
- $124,164
- From this org
- $105,910
- From related orgs
- $0
- Other
- $18,254
- Hours/week
- 40
-
Mike FrickMIKE FRICK
TB PROGRAM CO-DIRECTOR
- Total calculated
- $124,164
- From this org
- $105,910
- From related orgs
- $0
- Other
- $18,254
- Hours/week
- 40
-
Christopher GeorgeCHRISTOPHER GEORGE
DIRECTOR OF FINANCE
- Total calculated
- $104,500
- From this org
- $104,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$8,350
FUNDS PAID OUT AS FISCAL SPONSOR-HIV ADVOCACY
-
FUNDS PAID OUT AS FISCAL SPONSOR-TB ADVOCACY
Fundraising and gaming
From Schedule G of this return, as filed.
- Had an agreement with a professional fundraiser (line 2a)
- Not answered
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 RIAA | Total |
|---|---|---|
| Gross receipts (line 1) | $242,151 | $242,151 |
| Less contributions (line 2) | $204,526 | $204,526 |
| Gross income (line 3) | $37,625 | $37,625 |
| Cash prizes (line 4) | — | — |
| Noncash prizes (line 5) | — | — |
| Rent and facility costs (line 6) | $14,625 | $14,625 |
| Food and beverages (line 7) | $23,000 | $23,000 |
| Entertainment (line 8) | — | — |
| Other direct expenses (line 9) | — | — |
- Direct expenses (line 10)
- $37,625
- Net income (line 11)
- $0
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $425,510
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | HCV - LAT CAB | $450 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | 0 | 0 | PROGRAM SERVICES | TB - UNION CONFERENCE - PARIS | $92,457 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | 0 | 0 | PROGRAM SERVICES | POLICY - AMR MEETING - ROME | $341 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | REGIONAL CAB SUPPORT | $57,069 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTS | TB ADVOCACY/CAB SUPPORT | $21,173 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | GRANTS | TB ADVOCACY/CAB SUPPORT | $52,861 |
| SOUTH ASIA | 0 | 0 | GRANTS | TB ADVOCACY/CAB SUPPORT | $24,978 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTS | TB ADVOCACY/CAB SUPPORT | $170,181 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTS | HCV - LAT CAB/CONSULTANCY | $6,000 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| EAST ASIA AND THE PACIFIC | $21,173 | BANK WIRE | $0 | — | — |
| RUSSIA AND NEIGHBORING STATES | $52,861 | BANK WIRE | $0 | — | — |
| SOUTH ASIA | $12,500 | BANK WIRE | $0 | — | — |
| SOUTH ASIA | $12,478 | BANK WIRE | $0 | — | — |
| SUB-SAHARAN AFRICA | $59,068 | BANK WIRE | $0 | — | — |
| SUB-SAHARAN AFRICA | $25,000 | BANK WIRE | $0 | — | — |
| SUB-SAHARAN AFRICA | $25,000 | BANK WIRE | $0 | — | — |
| SUB-SAHARAN AFRICA | $25,595 | BANK WIRE | $0 | — | — |
| SUB-SAHARAN AFRICA | $25,000 | BANK WIRE | $0 | — | — |
Grants to individuals, by region (Part III)
The type of assistance is not shown.
| Region | Recipients | Cash grants | Manner of disbursement | Noncash assistance |
|---|---|---|---|---|
| SUB-SAHARAN AFRICA | 1 | $6,000 | BANK WIRE | — |
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 4 November 2024
- IRS schema version
- 2023v5.1
- Source object
- 202403129349302165
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.